Physician profile
Pratibha Rayapati
NPI 1225456486
$5,158.06
in general payments reported to CMS, 2019-2025
19 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.34 · 2020: $99.83 · 2021: $283 · 2022: $3,962 · 2023: $421 · 2024: $201 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $771.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $770.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,683.36 | 2021-2023 | Da Vinci Surgical System |
| Exeltis, USA INC. | $263.43 | 2020-2024 | Slynd |
| Abbvie INC. | $259.41 | 2020-2022 | |
| Pfizer INC. | $191.33 | 2021-2024 | |
| Integra Lifesciences Corporation | $148.23 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Mayne Pharma Commercial LLC | $110.38 | 2022-2024 | |
| Aspira Women'S Health INC | $68.25 | 2022 | |
| Mylan Pharmaceuticals INC. | $66.28 | 2021-2022 | |
| Roche Diagnostics Corporation | $58.97 | 2019-2020 | |
| Astellas Pharma US INC | $50.15 | 2023-2024 | Veozah |
| Millicent US INC | $48.72 | 2023-2024 | Femring, Intrarosa |
| Therapeuticsmd, INC. | $44.05 | 2020-2021 | |
| Gynesonics, INC. | $40.97 | 2021 | |
| Organon LLC | $34.08 | 2023-2024 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $29.61 | 2020-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $16.80 | 2022 | |
| Lsi Solutions INC | $15.89 | 2021 | |
| Avion Pharmaceuticals | $14.96 | 2021 | |
| Asensus Surgical, INC. | $13.19 | 2023 | Senhance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pratibha Rayapati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.